A prospective and open-label study for the efficacy and safety of telbivudine in pregnancy for the prevention of perinatal transmission of hepatitis B virus infection
Top Cited Papers
Open Access
- 18 April 2011
- journal article
- research article
- Published by Elsevier BV in Journal of Hepatology
- Vol. 55 (6), 1215-1221
- https://doi.org/10.1016/j.jhep.2011.02.032
Abstract
No abstract availableFunding Information
- Government of Jiangsu Province (H200804)
- Department of Health and Social Care (H200804)
This publication has 21 references indexed in Scilit:
- Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2008 updateHepatology International, 2008
- Hepatocellular carcinoma in TaiwanHepatology Research, 2007
- Two Decades of Universal Hepatitis B Vaccination in Taiwan: Impact and Implication for Future StrategiesGastroenterology, 2007
- TelbivudineNature Reviews Drug Discovery, 2007
- Nationwide Hepatitis B Vaccination Program in Taiwan: Effectiveness in the 20 Years After It Was LaunchedEpidemiologic Reviews, 2006
- Assessing the risk of birth defects associated with antiretroviral exposure during pregnancyAmerican Journal of Obstetrics and Gynecology, 2004
- Clinical Pharmacokinetics of LamivudineClinical Pharmacokinetics, 1999
- Failure of neonatal hepatitis B vaccination: the role of HBV-DNA levels in hepatitis B carrier mothers and HLA antigens in neonatesJournal of Hepatology, 1994
- Outcome Of Perinatal Hepatitis B Virus Exposure Is Dependent On Maternal Virus LoadThe Journal of Infectious Diseases, 1994
- Mechanisms of Maternal-Fetal Transmission of Hepatitis B VirusThe Journal of Infectious Diseases, 1978